Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer

International Journal of Cancer

Volumn 131, Issue 12, 2012, Pages 2795-2807

  Imoto, Akira ^a,b   Mitsunaga, Shuichi ^a   Inagaki, Masatoshi ^c   Aoyagi, Kazuhiko ^d   Sasaki, Hiroki ^d   Ikeda, Masafumi ^a   Nakachi, Kohei ^a   Higuchi, Kazuhide ^b   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

animal model; cachexia; glial activation; neural invasion; pancreatic cancer

Indexed keywords

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; ASTROCYTE; BODY FAT; BODY WEIGHT; CACHEXIA; CANCER CELL; CANCER INVASION; CELL ACTIVATION; CELL DISRUPTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NERVE CELL; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SKELETAL MUSCLE; SPINAL CORD;

ANIMALS; ASTROCYTES; CACHEXIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; NERVOUS SYSTEM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84867841973     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27594     Document Type: Article

References (50)

1. Tisdale MJ,. Cancer cachexia. Langenbecks Arch Surg 2004; 389: 299-305.
2. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69: 491-7.
3. Ikeda M, Okada S, Tokuuye K, et al. Prognostic factors in patients with locallyadvanced pancreatic carcinoma receiving chemoradiotherapy. Cancer 2001; 91: 490-5.
4. Nieto J, Grossbard ML, Kozuch P,. Metastatic pancreatic cancer 2008: is the glass less empty? Oncologist 2008; 13: 562-76.
5. Bachmann J, Ketterer K, Marsch C, et al. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 2009; 9: 255.
6. Bibby MC, Double JA, Ali SA, et al. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. J Natl Cancer Inst 1987; 78: 539-46.
7. Mitsunaga S, Hasebe T, Kinoshita T, et al. Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact. Am J Surg Pathol 2007; 31: 1636-44.
8. Mitsunaga S, Kinoshita T, Hasebe T, et al. Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion. Pancreas 2008; 36: 241-8.
9. Bockman DE, Buchler M, Beger HG,. Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology 1994; 107: 219-30.
10. Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. Pancreatic neuropathy and neuropathic pain-a comprehensive pathomorphological study of 546 cases. Gastroenterology 2009; 136: 177-86 e1.
11. Rutkowski MD, Winkelstein BA, Hickey WF, et al. Lumbar nerve root injury induces central nervous system neuroimmune activation and neuroinflammation in the rat: relationship to painful radiculopathy. Spine 2002; 27: 1604-13.
12. Hashizume H, DeLeo JA, Colburn RW, et al. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 2000; 25: 1206-17.
13. Gwak YS, Crown ED, Unabia GC, et al. Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat. Pain 2008; 138: 410-22.
14. Sweitzer SM, Schubert P, DeLeo JA,. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 2001; 297: 1210-7.
15. Tanga FY, Nutile-McMenemy N, DeLeo JA,. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 2005; 102: 5856-61.
16. Feng QX, Wang W, Feng XY, et al. Astrocytic activation in thoracic spinal cord contributes to persistent pain in rat model of chronic pancreatitis. Neuroscience 2010; 167: 501-9.
17. Neusch C, Bahr M, Schneider-Gold C. Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve 2007; 35: 712-24.
18. Papadimitriou D, Le Verche V, Jacquier A, et al. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis 2010; 37: 493-502.
19. Fukuda T, Iwanaga S, Sakamoto I, et al. CT of neural plexus invasion in common bile duct carcinoma. J Comput Assist Tomogr 1998; 22: 351-6.
20. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-9.
21. Mitsunaga S, Fujii S, Ishii G, et al. Nerve invasion distance is dependent on laminin gamma2 in tumors of pancreatic cancer. Int J Cancer 2010; 127: 805-19.
22. Tisdale MJ,. Cancer cachexia. Br J Cancer 1991; 63: 337-42.
23. Bujalska IJ, Hewitt KN, Hauton D, et al. Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue. Endocrinology 2008; 149: 2584-91.
24. Hald A, Nedergaard S, Hansen RR, et al. Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. Eur J Pain 2009; 13: 138-45.
25. Obara I, Mika J, Schafer MK, et al. Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation. Br J Pharmacol 2003; 140: 538-46.
26. Zhang X, Xu ZO, Shi TJ, et al. Regulation of expression of galanin and galanin receptors in dorsal root ganglia and spinal cord after axotomy and inflammation. Ann NY Acad Sci 1998; 863: 402-13.
27. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704-8.
28. Gordon JN, Green SR, Goggin PM,. Cancer cachexia. QJM 2005; 98: 779-88.
29. Ringheim GE,. Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia. Ann NY Acad Sci 2000; 903: 529-34.
30. Hinkle RT, Dolan E, Cody DB, et al. Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy. Muscle Nerve 2005; 32: 775-81.
31. Gomes MD, Lecker SH, Jagoe RT, et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98: 14440-5.
32. Gallagher D, Visser M, Sepulveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996; 143: 228-39.
33. Qvisth V, Hagstrom-Toft E, Enoksson S, et al. Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo. J Clin Endocrinol Metab 2006; 91: 665-70.
34. Dodt C, Lonnroth P, Wellhoner JP, et al. Sympathetic control of white adipose tissue in lean and obese humans. Acta Physiol Scand 2003; 177: 351-7.
35. Esper DH, Harb WA,. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract 2005; 20: 369-76.
36. Cahill GF Jr., Starvation in man. Clin Endocrinol Metab 1976; 5: 397-415.
37. Waterhouse C,. How tumors affect host metabolism. Ann NY Acad Sci 1974; 230: 86-93.
38. Xu M, Bruchas MR, Ippolito DL, et al. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. J Neurosci 2007; 27: 2570-81.
39. Bura SA, Nadal X, Ledent C, et al. A 2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury. Pain 2008; 140: 95-103.
40. Deer EL, Gonzalez-Hernandez J, Coursen JD, et al. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010; 39: 425-35.
41. Lynch GS, Ryall JG,. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev 2008; 88: 729-67.
42. Goldberg RM, Loprinzi CL, Mailliard JA, et al. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995; 13: 2856-9.
43. Uhlar CM, Whitehead AS,. The kinetics and magnitude of the synergistic activation of the serum amyloid A promoter by IL-1 beta and IL-6 is determined by the order of cytokine addition. Scand J Immunol 1999; 49: 399-404.
44. Uhlar CM, Whitehead AS,. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265: 501-23.
45. Zidek Z,. Adenosine-cyclic AMP pathways and cytokine expression. Eur Cytokine Netw 1999; 10: 319-28.
46. Leimbach WN Jr, Wallin BG, Victor RG, et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-9.
47. Nakagawa T, Kaneko S,. Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 2010; 114: 347-53.
48. Matsuki T, Horai R, Sudo K, et al. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 2003; 198: 877-88.
49. Ji C, Chen X, Gao C, et al. IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. J Bioenerg Biomembr 2011; 43: 367-75.
50. Collins S, Surwit RS,. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 2001; 56: 309-28.